Company news

DiaMedica Therapeutics Inc. news in 2019

DiaMedica Therapeutics Inc.'s news releases, calls and decks from 2019, newest first.

View company

DiaMedica Therapeutics Announces First Patient Dosed in REDUX Phase II Clinical Trial of DM199 for the Treatment of Chronic Kidney Disease

December 16, 2019

DiaMedica Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Update

November 12, 2019

DiaMedica Therapeutics to Report Third Quarter 2019 Financials and Provide a Business Update November 14, 2019

November 5, 2019

DiaMedica Therapeutics Announces Clearance to Initiate Phase II Clinical Trial of DM199 for Chronic Kidney Disease

October 13, 2019

Decks in 2019